BioSig Technologies (BSGM) Competitors $1.06 +0.04 (+3.40%) As of 10:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock BSGM vs. BDMD, OM, TELA, MODD, FEMY, POCI, DRIO, MDAI, PYPD, and COCHShould you be buying BioSig Technologies stock or one of its competitors? The main competitors of BioSig Technologies include Baird Medical Investment (BDMD), Outset Medical (OM), TELA Bio (TELA), Modular Medical (MODD), Femasys (FEMY), Precision Optics (POCI), DarioHealth (DRIO), Spectral AI (MDAI), PolyPid (PYPD), and Envoy Medical (COCH). These companies are all part of the "medical equipment" industry. BioSig Technologies vs. Baird Medical Investment Outset Medical TELA Bio Modular Medical Femasys Precision Optics DarioHealth Spectral AI PolyPid Envoy Medical Baird Medical Investment (NASDAQ:BDMD) and BioSig Technologies (NASDAQ:BSGM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, community ranking, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment. Do analysts recommend BDMD or BSGM? BioSig Technologies has a consensus price target of $2.50, suggesting a potential upside of 134.74%. Given BioSig Technologies' stronger consensus rating and higher probable upside, analysts plainly believe BioSig Technologies is more favorable than Baird Medical Investment.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00BioSig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to BDMD or BSGM? In the previous week, Baird Medical Investment had 3 more articles in the media than BioSig Technologies. MarketBeat recorded 4 mentions for Baird Medical Investment and 1 mentions for BioSig Technologies. BioSig Technologies' average media sentiment score of 1.44 beat Baird Medical Investment's score of 0.42 indicating that BioSig Technologies is being referred to more favorably in the news media. Company Overall Sentiment Baird Medical Investment Neutral BioSig Technologies Positive Which has preferable earnings & valuation, BDMD or BSGM? Baird Medical Investment has higher revenue and earnings than BioSig Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBaird Medical Investment$33.05M1.11N/AN/AN/ABioSig Technologies$40K645.71-$29.04MN/AN/A Does the MarketBeat Community believe in BDMD or BSGM? BioSig Technologies received 104 more outperform votes than Baird Medical Investment when rated by MarketBeat users. CompanyUnderperformOutperformBaird Medical InvestmentN/AN/ABioSig TechnologiesOutperform Votes10470.75% Underperform Votes4329.25% Which has more risk & volatility, BDMD or BSGM? Baird Medical Investment has a beta of -0.73, meaning that its share price is 173% less volatile than the S&P 500. Comparatively, BioSig Technologies has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Is BDMD or BSGM more profitable? Baird Medical Investment has a net margin of 0.00% compared to BioSig Technologies' net margin of -44,832.50%. Company Net Margins Return on Equity Return on Assets Baird Medical InvestmentN/A N/A N/A BioSig Technologies -44,832.50%N/A -776.49% Do institutionals and insiders believe in BDMD or BSGM? 19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 7.2% of BioSig Technologies shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by company insiders. Comparatively, 17.0% of BioSig Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryBioSig Technologies beats Baird Medical Investment on 7 of the 13 factors compared between the two stocks. Get BioSig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBioSig TechnologiesElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$25.83M$3.20B$5.51B$7.93BDividend YieldN/A1.80%5.11%4.22%P/E RatioN/A15.4722.5518.49Price / Sales645.7152.88394.97102.66Price / CashN/A44.0938.1834.62Price / Book-3.233.526.694.25Net Income-$29.04M$94.03M$3.22B$248.31M7 Day Performance26.79%2.05%1.11%1.12%1 Month Performance91.89%5.37%3.59%3.68%1 Year Performance-46.48%-17.93%15.65%5.19% BioSig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBioSig Technologies2.272 of 5 stars$1.07+3.4%$2.50+134.7%-38.0%$25.83M$40,000.000.0050Gap UpBDMDBaird Medical InvestmentN/A$5.55-0.7%N/AN/A$36.54M$33.05M0.00N/AOMOutset Medical1.048 of 5 stars$9.98-9.4%$35.00+250.7%-72.0%$35.88M$113.69M-4.02520Upcoming EarningsTELATELA Bio2.9792 of 5 stars$0.89-6.9%$7.25+714.6%-78.5%$35.06M$69.30M-0.53120Upcoming EarningsShort Interest ↓MODDModular Medical1.9626 of 5 stars$0.85-4.2%N/A-31.6%$34.61MN/A-1.6120Short Interest ↓Negative NewsFEMYFemasys3.4127 of 5 stars$1.20-3.2%$11.50+858.3%-8.7%$32.58M$1.63M-1.4830Upcoming EarningsShort Interest ↓Gap DownPOCIPrecision Optics0.6287 of 5 stars$3.99+1.0%N/A-20.7%$30.59M$18.68M-6.2380Positive NewsGap UpDRIODarioHealth2.5467 of 5 stars$0.73-2.7%$1.50+105.5%-49.6%$30.34M$27.04M-0.78200News CoveragePositive NewsMDAISpectral AI2.9815 of 5 stars$1.18-4.8%$4.75+302.5%-27.0%$29.87M$29.58M-1.8283Upcoming EarningsShort Interest ↓News CoverageGap DownPYPDPolyPid2.1415 of 5 stars$2.75+0.4%$11.33+312.1%-40.3%$28.03MN/A-0.5580Upcoming EarningsShort Interest ↑News CoverageGap UpCOCHEnvoy Medical2.3628 of 5 stars$1.31-2.2%$9.13+596.6%-66.6%$27.94M$225,000.00-0.9334 Related Companies and Tools Related Companies Baird Medical Investment Competitors Outset Medical Competitors TELA Bio Competitors Modular Medical Competitors Femasys Competitors Precision Optics Competitors DarioHealth Competitors Spectral AI Competitors PolyPid Competitors Envoy Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BSGM) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BSGM Stock Free BSGM Stock Alerts